Products for Research Use Only
RegisterLogin

PRL-3 Inhibitor (Compound 5e)

CAT: 0957-E0140Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-E0140Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PRL-3 Inhibitor (Compound 5e) is a potent PRL-3 inhibitor with an IC50 of 0.9 μM.
CAS Number
893449-38-2
Target
Phosphatase
Activity
Metabolism
Molecular Formula
C17H11Br2NO2S2
Storage Conditions
3 years -20°C powder

Chemical Information

PRL-3 inhibitor I

5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is an aromatic ether.

CAS Number893449-38-2
PubChem CID11983303
IUPAC Name(5Z)-5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
Molecular FormulaC17H11Br2NO2S2
Molecular Weight485.2
XLogP5.6
Topological Polar Surface Area95.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Heavy Atom Count24
Formal Charge0
Complexity529
SMILES
C1=CC=C(C(=C1)COC2=C(C=C(C=C2)Br)/C=C\3/C(=O)NC(=S)S3)Br
InChI
InChI=1S/C17H11Br2NO2S2/c18-12-5-6-14(22-9-10-3-1-2-4-13(10)19)11(7-12)8-15-16(21)20-17(23)24-15/h1-8H,9H2,(H,20,21,23)/b15-8-
InChIKey
HXNBAOLVPAWYLT-NVNXTCNLSA-N
Chemical Structure
2D Structure
2D structure of PRL-3 inhibitor I
CAS: 893449-38-2
CID: 11983303
Formula: C17H11Br2NO2S2
MW: 485.2
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight485.2
XLogP35.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass484.85775
Monoisotopic Mass482.85980
Topological Polar Surface Area95.7 Ų
Heavy Atom Count24
Formal Charge0
Complexity529
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
E1637-1gALKBH5 inhibitor 1 (compound 3)
E1637-100mgALKBH5 inhibitor 1 (compound 3)
E1637-5mgALKBH5 inhibitor 1 (compound 3)
E1637-01ALKBH5 inhibitor 1 (compound 3)
E1637-25mgALKBH5 inhibitor 1 (compound 3)
S8616-1gPKM2 inhibitor (compound 3k)
S8616-01PKM2 inhibitor (compound 3k)
S8616-5mgPKM2 inhibitor (compound 3k)
S8616-25mgPKM2 inhibitor (compound 3k)
S8616-100mgPKM2 inhibitor (compound 3k)

Alternative Products

CatalogName
C01103PRL-3 Inhibitor (Compound 5e)
C01778-1gALKBH5 inhibitor 1 (compound 3)
217388Glutaminase Inhibitor, Compound 968 (5- (3-Bromo-4- (dimethylamino) phenyl) -2,2-dimethyl-2,3,5,6-tetrahydrobenzo[a]phenanthridin-4 (1H) -one, GAC Inhibitor, GLS1 Inhibitor I, KGA Inhibitor I, Kidney-Type Glutaminase Inhibitor I)
217317DNA Methyltransferase Inhibitor V, RSC133 (DNA MTase Inhibitor V, (E) -3- (3- (1H-Indol-3-yl) acrylamido) benzamide, ID133, iPSC Induction Enhancer III, Reprogramming Stimulating Compound 133)
029416-01AMPK Inhibitor, Compound C (6-[4- (2-Piperidin-1-yl-ethoxy) -phenyl) ]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, BMP Inhibitor I)
MBS6092861-01AMPK Inhibitor, Compound C (6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, BMP Inhibitor I)
217280-01Compound E, gamma-Secretase Inhibitor XXI ((S, S) -2-[2- (3,5-Difluorophenyl) -acetylamino]-N- (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl) -propionamide) discontinued. See 044679
217551Mirk/Dyrk1B Inhibitor, Compound A (N- (2-Chloro-5- (3-chlorobenzylcarbamoyl) phenyl) -2-methoxy-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide, N- (2-Chloro-5- ((3-chlorobenzyl) carbamoyl) phenyl) -7-hydroxy-2-methoxypyrido[2,3-d]pyrimidine-6-carboxamide) discontinued
217230BRD2 Inhibitor II, BIC1 (BRD2 Bromodomain-Interactive Compound, BIC1, 1- (2- (1H-Benzimidazol-2-ylsulfanyl) ethyl) -3-methyl-1,3-dihydro-2H-benzimidazole-2-thione, 1- (2- (1H-Benzo[d]imidazol-2-ylthio) ethyl) -3-methyl-1H-benzo[d]imidazole-2 (3H) -thione)
C3996-25PRL-3 Inhibitor

Popular Products